Cambridge Investment Research Advisors, Inc. Geron Corp Transaction History

Cambridge Investment Research Advisors, Inc.

$27.1 Billion
Q2 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Geron Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 189,225 shares of GERN stock, worth $809,883. This represents 0.0% of its overall portfolio holdings.

Number of Shares

189,225

Previous 193,175 2.04%

Holding current value

$809,883

Previous $637,000 25.9%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$3.1 - $5.09 $12,245 - $20,105	-3,950 Reduced 2.04%	189,225 $802,000
Q1 2024 Apr 24, 2024	SELL	$1.75 - $3.44 $56,346 - $110,761	-32,198 Reduced 14.29%	193,175 $637,000
Q4 2023 Feb 09, 2024	SELL	$1.74 - $2.31 $62,852 - $83,441	-36,122 Reduced 13.81%	225,373 $476,000
Q3 2023 Oct 24, 2023	SELL	$2.11 - $3.28 $99,423 - $154,553	-47,120 Reduced 15.27%	261,495 $554,000
Q2 2023 Jul 13, 2023	BUY	$1.97 - $3.69 $199,955 - $374,535	101,500 Added 49.01%	308,615 $991,000
Q1 2023 May 11, 2023	SELL	$2.14 - $3.4 $73,543 - $116,844	-34,366 Reduced 14.23%	207,115 $449,000
Q4 2022 Feb 08, 2023	SELL	$2.03 - $2.42 $61,630 - $73,471	-30,360 Reduced 11.17%	241,481 $584,000
Q3 2022 Oct 17, 2022	BUY	$1.67 - $2.94 $80,160 - $141,120	48,000 Added 21.44%	271,841 $636,000
Q2 2022 Jul 13, 2022	SELL	$1.19 - $1.65 $41,650 - $57,750	-35,000 Reduced 13.52%	223,841 $346,000
Q1 2022 May 12, 2022	SELL	$0.99 - $1.6 $17,770 - $28,720	-17,950 Reduced 6.49%	258,841 $352,000
Q4 2021 Feb 03, 2022	SELL	$1.22 - $1.72 $9,369 - $13,209	-7,680 Reduced 2.7%	276,791 $337,000
Q3 2021 Nov 02, 2021	SELL	$1.2 - $1.5 $2,580 - $3,225	-2,150 Reduced 0.75%	284,471 $389,000
Q2 2021 Aug 10, 2021	SELL	$1.25 - $1.83 $7,500 - $10,980	-6,000 Reduced 2.05%	286,621 $404,000
Q1 2021 May 07, 2021	SELL	$1.52 - $2.1 $52,721 - $72,838	-34,685 Reduced 10.6%	292,621 $462,000
Q4 2020 Feb 04, 2021	SELL	$1.55 - $2.05 $55,806 - $73,808	-36,004 Reduced 9.91%	327,306 $520,000
Q3 2020 Oct 29, 2020	BUY	$1.59 - $2.19 $4,862 - $6,697	3,058 Added 0.85%	363,310 $632,000
Q2 2020 Jul 27, 2020	BUY	$1.05 - $2.18 $93,408 - $193,932	88,960 Added 32.79%	360,252 $785,000
Q1 2020 May 08, 2020	BUY	$0.89 - $1.49 $19,580 - $32,780	22,000 Added 8.82%	271,292 $322,000
Q4 2019 Feb 04, 2020	BUY	$1.27 - $1.54 $292,413 - $354,580	230,247 Added 1208.96%	249,292 $339,000
Q1 2019 May 08, 2019	SELL	$1.01 - $1.83 $606 - $1,098	-600 Reduced 3.05%	19,045 $0
Q4 2018 Feb 05, 2019	SELL	$0.98 - $1.85 $5,854 - $11,051	-5,974 Reduced 23.32%	19,645 $19,000
Q3 2018 Nov 02, 2018	BUY	$1.76 - $6.38 $26,547 - $96,235	15,084 Added 143.18%	25,619 $0
Q2 2018 Aug 10, 2018	BUY	$3.29 - $4.82 $34,660 - $50,778	10,535 New	10,535 $0

Others Institutions Holding GERN

# of Institutions

258

Shares Held

448M

Call Options Held

1.91M

Put Options Held

897K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.62B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Geron Corp Transaction History